Jonathan Spicer
About
Jonathan Spicer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Jonathan Spicer has authored 157 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pulmonary and Respiratory Medicine, 59 papers in Oncology and 56 papers in Surgery. Recurrent topics in Jonathan Spicer's work include Lung Cancer Diagnosis and Treatment (54 papers), Cancer Immunotherapy and Biomarkers (32 papers) and Esophageal Cancer Research and Treatment (32 papers). Jonathan Spicer is often cited by papers focused on Lung Cancer Diagnosis and Treatment (54 papers), Cancer Immunotherapy and Biomarkers (32 papers) and Esophageal Cancer Research and Treatment (32 papers). Jonathan Spicer collaborates with scholars based in Canada, United States and Spain. Jonathan Spicer's co-authors include Lorenzo Ferri, Jonathan Cools‐Lartigue, Betty Giannias, Braedon McDonald, France Bourdeau, Simon C. Chow, Paul Kubes, Stephen Gowing, Sara Najmeh and Simon Rousseau and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.
In The Last Decade
Jonathan Spicer
138 papers receiving 5.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jonathan Spicer Canada | 30 | 2.4k | 2.1k | 1.6k | 939 | 878 | 157 | 5.5k | ||
| Jonathan Cools‐Lartigue Canada | 23 | 1.8k 0.8× | 1.1k 0.5× | 681 0.4× | 789 0.8× | 576 0.7× | 97 | 3.6k | ||
| Daniel Neureiter Austria | 42 | 738 0.3× | 1.5k 0.7× | 863 0.5× | 1.2k 1.3× | 2.1k 2.4× | 241 | 5.9k | ||
| Santos Castañeda Spain | 38 | 1.2k 0.5× | 663 0.3× | 1.0k 0.7× | 722 0.8× | 1.1k 1.3× | 298 | 5.6k | ||
| John E. Levine United States | 48 | 3.8k 1.6× | 2.2k 1.0× | 674 0.4× | 661 0.7× | 1.4k 1.6× | 201 | 9.5k | ||
| Nicolás Meyer France | 34 | 1.1k 0.5× | 2.4k 1.1× | 760 0.5× | 289 0.3× | 1.3k 1.5× | 189 | 4.7k | ||
| Stefan Burdach Germany | 44 | 2.2k 0.9× | 2.0k 0.9× | 2.1k 1.3× | 771 0.8× | 2.1k 2.4× | 210 | 7.3k | ||
| Michael von Bergwelt‐Baildon Germany | 41 | 2.3k 1.0× | 3.4k 1.6× | 717 0.5× | 296 0.3× | 1.1k 1.2× | 214 | 6.3k | ||
| Jacob M. van Laar Netherlands | 47 | 2.4k 1.0× | 698 0.3× | 1.2k 0.8× | 572 0.6× | 1.1k 1.3× | 251 | 7.5k | ||
| Barbara A. Konkle United States | 41 | 706 0.3× | 1.0k 0.5× | 470 0.3× | 1.3k 1.4× | 1.6k 1.8× | 216 | 8.0k | ||
| Heinz Regele Austria | 45 | 1.8k 0.8× | 911 0.4× | 993 0.6× | 2.4k 2.6× | 1.2k 1.3× | 188 | 6.9k |
Countries citing papers authored by Jonathan Spicer
Since
Specialization
Citations
This map shows the geographic impact of Jonathan Spicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Spicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Spicer more than expected).
Fields of papers citing papers by Jonathan Spicer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jonathan Spicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Spicer. The network helps show where Jonathan Spicer may publish in the future.
Co-authorship network of co-authors of Jonathan Spicer
This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Spicer. A scholar is included among the top collaborators of Jonathan Spicer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Spicer. Jonathan Spicer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Esfahani, Khashayar, Khalil Sultanem, Jonathan Spicer, et al.. (2025). “Tension Chyle Leak”: A Life‐Threatening Sequela of Thoracic Duct Injury Following Resection of BRAF ‐Mutated Anaplastic Thyroid Carcinoma. Head & Neck. 47(6). E64–E67.
2.
Gallina, Filippo Tommaso, Daniele Marinelli, Paolo Visca, et al.. (2025). TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma. European Journal of Cancer. 227. 115622–115622.
3.
Reck, Martin, Ernest Nadal, Nicolas Girard, et al.. (2024). MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB–IIIB NSCLC. Clinical Lung Cancer. 25(6). 587–593.e3.
4.
Awad, Mark M., Tina Cascone, Jonathan Spicer, et al.. (2024). LBA2 Clinical outcomes with perioperative nivolumab (NIVO) in patients (PTS) with resectable NSCLC from the phase III CheckMate 77T study. ESMO Open. 9. 102985–102985.
5.
Majem, Margarita, Roger Keresztes, Yinjun Lou, et al.. (2024). LBA3 Perioperative pembrolizumab (pembro) plus neoadjuvant chemotherapy (chemo) in early-stage non-small-cell lung cancer (NSCLC): A 4-year update of KEYNOTE-671. Immuno-Oncology Technology. 24. 101027–101027.
6.
Garassino, Marina Chiara, Heather A. Wakelee, Jonathan Spicer, et al.. (2024). Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8012–8012.
7.
Spicer, Jonathan, Nicolas Girard, Mariano Provencio, et al.. (2024). Neoadjuvant nivolumab (NIVO) + chemotherapy (chemo) vs chemo in patients (pts) with resectable NSCLC: 4-year update from CheckMate 816.. Journal of Clinical Oncology. 42(17_suppl). LBA8010–LBA8010.
8.
Tankel, James, Andrew C. Meng, Sara Najmeh, et al.. (2024). ERAS following Gastrectomy for Octo- and Nonagenarians: A Single-Center Retrospective Analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques. 34(6). 484–489.
9.
Melosky, Barbara, Mark Vincent, Anna McGuire, et al.. (2024). Modern era systemic therapies: Expanding concepts of cure in early and locally advanced non‐small cell lung cancer. International Journal of Cancer. 155(6). 963–978.
10.
Wakelee, Heather A., Moïshe Liberman, Terufumi Kato, et al.. (2023). KEYNOTE-671: Randomized, double-blind, phase 3 study of pembrolizumab or placebo plus platinum-based chemotherapy followed by resection and pembrolizumab or placebo for early stage NSCLC.. Journal of Clinical Oncology. 41(17_suppl). LBA100–LBA100.
11.
Rayes, Roni, Jonathan Cools‐Lartigue, Jonathan Spicer, et al.. (2023). OA20.06 Quantification of Pathologically Assessed Lymph Node Area in Lung Cancer Resection Using Deep Learning. Journal of Thoracic Oncology. 18(11). S92–S92.
12.
Kamińska, Marta, et al.. (2023). Lobar Torsion Following Open Repair of Type B Aortic Dissection and Thoracoabdominal Aortic Aneurysm in a Patient with Marfan Syndrome. EJVES Vascular Forum. 60. 8–11.
13.
Tankel, James, Jonathan Spicer, Quincy S. Chu, et al.. (2023). Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process. Current Oncology. 30(12). 10363–10384.
14.
Camilleri‐Broët, Sophie, Caroline Huynh, Leora Witkowski, et al.. (2023). Next-generation sequencing of non-small cell lung cancer at a Quebec health care cancer centre. Cancer Treatment and Research Communications. 35. 100696–100696.
15.
Provencio, Mariano, Virginia Calvo, Atocha Romero, Jonathan Spicer, & Alberto Cruz‐Bermúdez. (2022). Treatment Sequencing in Resectable Lung Cancer: The Good and the Bad of Adjuvant Versus Neoadjuvant Therapy. American Society of Clinical Oncology Educational Book. 42(42). 711–728.
16.
Rayes, Roni, Phil Vourtzoumis, Rashmi Seth, et al.. (2020). Neutrophil Extracellular Trap–Associated CEACAM1 as a Putative Therapeutic Target to Prevent Metastatic Progression of Colon Carcinoma. The Journal of Immunology. 204(8). 2285–2294.
17.
Bouchard, Philippe, Juan Carlos Molina, Jonathan Cools‐Lartigue, et al.. (2019). Endoscopic Submucosal Dissection for Esophageal Adenocarcinoma: A North American Perspective. Journal of Gastrointestinal Surgery. 23(6). 1087–1094.
18.
Rayes, Roni, Ioana Nicolau, France Bourdeau, et al.. (2019). Primary tumors induce neutrophil extracellular traps with targetable metastasis-promoting effects. JCI Insight. 4(16).
19.
Spicer, Jonathan, Braedon McDonald, Jonathan Cools‐Lartigue, et al.. (2012). Neutrophils Promote Liver Metastasis via Mac-1–Mediated Interactions with Circulating Tumor Cells. Cancer Research. 72(16). 3919–3927.
20.
Tabariès, Sébastien, Fanny Dupuy, Zhifeng Dong, et al.. (2012). Claudin-2 Promotes Breast Cancer Liver Metastasis by Facilitating Tumor Cell Interactions with Hepatocytes. Molecular and Cellular Biology. 32(15). 2979–2991.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jonathan Cools‐Lartigue Breakdown of academic impact, for papers by Daniel Neureiter Breakdown of academic impact, for papers by Santos Castañeda Breakdown of academic impact, for papers by John E. Levine Breakdown of academic impact, for papers by Nicolás Meyer Breakdown of academic impact, for papers by Stefan Burdach Breakdown of academic impact, for papers by Michael von Bergwelt‐Baildon Breakdown of academic impact, for papers by Jacob M. van Laar Breakdown of academic impact, for papers by Barbara A. Konkle Breakdown of academic impact, for papers by Heinz Regele